ResBiotic Subsidiary Alveolus Bio Focused on Lung, Gut Health

ResBiotic Subsidiary Alveolus Bio Focused on Lung, Gut Health

310982

ResBiotic Subsidiary Alveolus Bio Focused on Lung, Gut Health

The biotech startup ResBiotic has created a lung disease-focused pharmaceutical spin-off — Alveolus Bio — and launched its first probiotic-based consumer health product called resB Lung Support. The parent company, based in Birmingham, Alabama, and its subsidiary are using $4.5 million in seed funding “to transform the respiratory care landscape and chart new frontiers for [microbiota-based] science,” according to a press release. The gastrointestinal tract is colonized by gut microbiota, a vast community of bacteria, fungi, and viruses…

You must be logged in to read/download the full post.